We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+18.1%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$1.52B
AUM Growth
+$95.3M
Cap. Flow
-$53M
Cap. Flow %
-3.48%
Top 10 Hldgs %
46.4%
Holding
811
New
169
Increased
201
Reduced
172
Closed
223

Top Buys

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$66.9M
2
SAGE
Sage Therapeutics
SAGE
+$26.6M
3
IMO icon
Imperial Oil
IMO
+$24.9M
4
COIN icon
Coinbase
COIN
+$22.5M
5
ANSCU
Agriculture & Natural Solutions Acquisition Corp Unit
ANSCU
+$21.6M

Top Sells

Rank Stock Value
1
MSOS icon
AdvisorShares Pure US Cannabis ETF
MSOS
+$48.7M
2
AAC
Ares Acquisition Corporation
AAC
+$36.4M
3
PTGX icon
Protagonist Therapeutics
PTGX
+$27.6M
4
HCVIU
Hennessy Capital Investment Corp. VI Unit
HCVIU
+$17.4M
5
NETD
Nabors Energy Transition Corp II
NETD
+$16.9M

Sector Composition

Rank Sector Weight
1 Healthcare 30.8%
2 Financials 24.54%
3 Technology 21.73%
4 Communication Services 4.41%
5 Energy 3.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SEDA
101
DELISTED
SDCL EDGE Acquisition Corporation
SEDA
$2.29M 0.15%
213,121
+182,642
+599% +$1.95M
CRESW
102
DELISTED
Cresud SACIF y A. Warrant
CRESW
$2.28M 0.15%
+3,034,316
New +$1.4M
BOWN
103
DELISTED
Bowen Acquisition Corp
BOWN
$2.27M 0.15%
219,855
-52,721
-19% -$541K
PEGR
104
DELISTED
Project Energy Reimagined Acquisition Corp. Class A Ordinary Share
PEGR
$2.25M 0.15%
212,735
-1,411,383
-87% -$14.8M
EXEL icon
105
Exelixis
EXEL
$13.1B
$2.22M 0.15%
+92,654
New +$2.01M
SDST
106
Stardust Power Inc
SDST
$7.27M
$2.21M 0.15%
20,000
-328
-2% -$36K
BMRN icon
107
BioMarin Pharmaceuticals
BMRN
$13.3B
$2.2M 0.14%
+22,865
New +$2.02M
BOCN
108
DELISTED
Blue Ocean Acquisition Corp Class A Ordinary Shares
BOCN
$2.19M 0.14%
203,505
-93,976
-32% -$1.01M
PORT
109
DELISTED
Southport Acquisition Corporation
PORT
$2.13M 0.14%
200,000
+108,268
+118% +$1.15M
CNGL
110
DELISTED
Canna-Global Acquisition Corp. Class A Common Stock
CNGL
$2.12M 0.14%
195,000
-5,000
-3% -$54.2K
KRYS icon
111
Krystal Biotech
KRYS
$9.81B
$2.06M 0.14%
+16,634
New +$1.84M
UTHR icon
112
United Therapeutics
UTHR
$22.7B
$2.05M 0.13%
+9,342
New +$2.15M
SGML icon
113
Sigma Lithium
SGML
$1.32B
$2.04M 0.13%
+64,685
New +$1.8M
GCTS
114
GCT Semiconductor Holding
GCTS
$225M
$2.02M 0.13%
+191,096
New +$2.03M
BNT
115
Brookfield Wealth Solutions
BNT
$12.2B
$2.01M 0.13%
74,828
+16,878
+29% +$383K
BACA
116
DELISTED
Berenson Acquisition Corp. I
BACA
$2.01M 0.13%
+196,284
New +$2.02M
HALO icon
117
Halozyme
HALO
$12.2B
$2M 0.13%
+54,034
New +$2.04M
TMTC
118
DELISTED
TMT Acquisition Corp Ordinary Shares
TMTC
$1.97M 0.13%
186,012
+107,461
+137% +$1.13M
ARYD
119
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$1.97M 0.13%
180,856
-11,705
-6% -$127K
WEL
120
DELISTED
Integrated Wellness Acquisition Corp
WEL
$1.82M 0.12%
+161,907
New +$1.79M
XGN icon
121
Exagen
XGN
$161M
$1.79M 0.12%
898,630
+56,254
+7% +$97.3K
IEI icon
122
iShares 3-7 Year Treasury Bond ETF
IEI
$17.7B
$1.76M 0.12%
15,000
-17,300
-54% -$1.97M
SRPT icon
123
Sarepta Therapeutics
SRPT
$1.81B
$1.64M 0.11%
+17,012
New +$1.63M
CITE
124
DELISTED
Cartica Acquisition Corp Class A Ordinary Shares
CITE
$1.64M 0.11%
150,000
-55,145
-27% -$598K
RIVN icon
125
Rivian
RIVN
$23.7B
$1.6M 0.1%
+68,000
New +$1.28M
3 4
5
6 7

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q4 2023 Portfolio in Review

As of Q4 2023, Cowen and Company held 811 positions worth $1.52B, up 6.7% from $1.43B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Cowen and Company withdrew a net $53M in Q4 2023, closing 223 positions and reducing 172 holdings. Its most notable exit was AdvisorShares Pure US Cannabis ETF, an estimated $48.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 22% a quarter earlier, followed by Financials and Technology.

Against the trend, Cowen and Company opened a new position in Sage Therapeutics worth $29M.

  • Cowen and Company's largest Q4 2023 buy was Sage Therapeutics: 1,339,971 shares worth $29M.
  • Cowen and Company added most to PTC Therapeutics in Q4 2023, an estimated $66.9M increase.
  • Cowen and Company's biggest Q4 2023 reduction was Nabors Energy Transition Corp II, cutting an estimated $16.9M.
  • Cowen and Company fully exited AdvisorShares Pure US Cannabis ETF in Q4 2023, selling an estimated $48.7M.
  • Cowen and Company's ten largest holdings make up 46% of its $1.52B portfolio in Q4 2023.
  • Cowen and Company opened 169 new positions and closed 223 in Q4 2023.
  • Cowen and Company's portfolio value rose 6.7% quarter-over-quarter to $1.52B.

Based on Cowen and Company's 13F filing for Q4 2023, filed 8 Feb 2024.